Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Gestational Diabetes: Screening

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: August 2021

Workgroups: Diabetes Workgroup, Maternal, Infant, and Child Health Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends screening for gestational diabetes at or after 24 weeks of pregnancy. This recommendation applies to pregnant women who haven't been diagnosed with type 1 or type 2 diabetes and who don't have symptoms of gestational diabetes. USPSTF found insufficient evidence to assess whether the benefits of gestational diabetes screening before 24 weeks of pregnancy outweigh the harms.

Read more about this resource

Objectives related to this resource (3)

Reduce the number of diabetes cases diagnosed yearly — D‑01
LHI label
Baseline only
Increase the proportion of pregnant women who receive early and adequate prenatal care — MICH‑08
Getting worse
Increase the proportion of women who had a healthy weight before pregnancy — MICH‑13
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2021). Final update summary: Gestational Diabetes: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening